Skip to content

Comparison of Single-Shot Liposomal Bupivacaine and Programmed Intermittent Bolus Bupivacaine Hydrochloride Erector Spinae Plane Block for Postoperative Analgesia after Minimally Invasive Coronary Artery Bypass Grafting

Comparison of Single-Shot Liposomal Bupivacaine and Programmed Intermittent Bolus Bupivacaine Hydrochloride Erector Spinae Plane Block for Postoperative Analgesia after Minimally Invasive Coronary Artery Bypass Grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118399
Enrollment
Unknown
Registered
2026-02-05
Start date
2026-02-05
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Postoperative Pain After Minimally Invasive Off-Pump Coronary Artery Bypass Grafting

Interventions

Experimental Group:Single liposomal bupivacaine Group
Active Comparator Group:Continuous bupivacaine hydrochloride group

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years; 2.Scheduled for elective minimally invasive cardiac surgery–coronary artery bypass grafting via a left anterolateral mini-thoracotomy;

Exclusion criteria

Exclusion criteria: 1.Contraindications to nerve block, including coagulopathy, local infection at the puncture site, thoracic spinal deformity, or history of thoracic spine surgery. 2.Inability to cooperate with nerve block procedures (e.g., patients with impaired consciousness or severe psychiatric disorders). 3.Hypersensitivity to ultrasound coupling agents, local anesthetics (e.g., bupivacaine, ropivacaine), or opioids. 4.History of chronic pain (defined as persistent or recurrent pain >= 3 months), including chronic pain resulting from previous surgery, trauma, or other diseases, or long-term use of oral analgesics. 5.Inability to comprehend pain assessment scales or operate patient-controlled analgesia devices. 6.Pregnancy or lactation. 7.History of coronary artery bypass grafting. 8.Participation in another clinical trial or refusal to participate in this study.

Design outcomes

Primary

MeasureTime frame
Area under the curve of cumulative resting pain scores within 72 hours after tracheal extubation;

Secondary

MeasureTime frame
Intraoperative observation indicators;Immediate complications;Postoperative delirium;Total opioid consumption within 72 hours postoperatively (converted to morphine milligram equivalents, MME);Area under the curve of cumulative resting pain scores within 72 hours after tracheal extubation;Postoperative recovery quality, Sleep quality, Postoperative Sedation Levels;The duration of the nerve block catheterization procedure;Long-term outcomes;Postoperative cardiac biomarkers and cardiovascular complications;Analgesia satisfaction;Postoperative respiratory function and respiratory complications;Adverse events;Immediate NRS score at puncture,Satisfaction with the puncture procedure;Anxiety and depressive states;Early postoperative recovery outcomes;The depth of the nerve block catheter placement;

Countries

China

Contacts

Public ContactMin Li

Peking University Third Hospital

liminanesth@bjmu.edu.cn+86 10 8226 7276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026